JASPER THERAPEUTICS, INC. Increase (Decrease) in Income Taxes Payable
JASPER THERAPEUTICS, INC. (JSPR) reported Increase (Decrease) in Income Taxes Payable of -$16.23 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2021-08-16
- JASPER THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2020-12-31 was -$7.91K.
- JASPER THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2020-09-30 was -$64.94K.
- JASPER THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2020-06-30 was -$1.20K.
- JASPER THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2020-03-31 was $57.82K.
- JASPER THERAPEUTICS, INC. increase (decrease) in income taxes payable for fiscal 2020 was -$16.23K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 5 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | -$7.91K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$72.85K derived: sum of 2 quarters · filed 2021-05-24 | -$74.05K derived: sum of 3 quarters · filed 2021-08-16 | -$16.23K 10-K/A · filed 2021-05-24 | |
| 2020-09-30 | -$64.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$66.14K derived: sum of 2 quarters · filed 2021-08-16 | -$8.31K 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | -$1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $56.63K 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $57.82K 10-Q · filed 2021-05-24 | ||||
| 2019-12-31 | $16.23K 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |